Drug: FLUDARABINE Injury: Acute lymphocytic leukaemia recurrent Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125251951 | FLUDARABINE | Acute lymphocytic leukaemia recurrent | BAXTER | 33.00 YR | F | 0 | 20160704 | US |
125351791 | FLUDARABINE | Acute lymphocytic leukaemia recurrent | BAXTER | 52.00 YR | M | 0 | 20160707 | CA |
126029761 | FLUDARABINE | Acute lymphocytic leukaemia recurrent | FRESENIUS KABI | 22.00 YR | M | 0 | 20160728 | GB |
126033341 | FLUDARABINE | Acute lymphocytic leukaemia recurrent | ACTAVIS | 22.00 YR | M | 0 | 20160728 | GB |
127112121 | FLUDARABINE | Acute lymphocytic leukaemia recurrent | BAXTER | 5.41 YR | M | 0 | 20160902 | GR |
127761161 | FLUDARABINE | Acute lymphocytic leukaemia recurrent | BAXTER | 56.00 YR | F | 0 | 20160923 | US |
Total Records: 6 Number of Pages: 1